ASC-1 is a cell cycle regulator associated with severe and mild forms of myopathy
<p><strong>Objective</strong> Recently, the ASC‐1 complex has been identified as a mechanistic link between amyotrophic lateral sclerosis and spinal muscular atrophy (SMA), and 3 mutations of the ASC‐1 gene TRIP4 have been associated with SMA or congenital myopathy. Our goal was to...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Wiley
2019
|
| _version_ | 1797080323903717376 |
|---|---|
| author | Villar-Quiles, RN Catervi, F Cabet, E Juntas-Morales, R Genetti, CA Gidaro, T Koparir, A Yüksel, A Coppens, S Deconinck, N Pierce-Hoffman, E Lornage, X Durigneux, J Laporte, J Rendu, J Romero, NB Beggs, AH Servais, LJP Cossée, M Olivé, M Böhm, J Duband-Goulet, I Ferreiro, A |
| author_facet | Villar-Quiles, RN Catervi, F Cabet, E Juntas-Morales, R Genetti, CA Gidaro, T Koparir, A Yüksel, A Coppens, S Deconinck, N Pierce-Hoffman, E Lornage, X Durigneux, J Laporte, J Rendu, J Romero, NB Beggs, AH Servais, LJP Cossée, M Olivé, M Böhm, J Duband-Goulet, I Ferreiro, A |
| author_sort | Villar-Quiles, RN |
| collection | OXFORD |
| description | <p><strong>Objective</strong>
Recently, the ASC‐1 complex has been identified as a mechanistic link between amyotrophic lateral sclerosis and spinal muscular atrophy (SMA), and 3 mutations of the ASC‐1 gene TRIP4 have been associated with SMA or congenital myopathy. Our goal was to define ASC‐1 neuromuscular function and the phenotypical spectrum associated with TRIP4 mutations.</p>
<p><strong>Methods</strong>
Clinical, molecular, histological, and magnetic resonance imaging studies were made in 5 families with 7 novel TRIP4 mutations. Fluorescence activated cell sorting and Western blot were performed in patient‐derived fibroblasts and muscles and in Trip4 knocked‐down C2C12 cells.</p>
<p><strong>Results</strong>
All mutations caused ASC‐1 protein depletion. The clinical phenotype was purely myopathic, ranging from lethal neonatal to mild ambulatory adult patients. It included early onset axial and proximal weakness, scoliosis, rigid spine, dysmorphic facies, cutaneous involvement, respiratory failure, and in the older cases, dilated cardiomyopathy. Muscle biopsies showed multiminicores, nemaline rods, cytoplasmic bodies, caps, central nuclei, rimmed fibers, and/or mild endomysial fibrosis. ASC‐1 depletion in C2C12 and in patient‐derived fibroblasts and muscles caused accelerated proliferation, altered expression of cell cycle proteins, and/or shortening of the G0/G1 cell cycle phase leading to cell size reduction.</p>
<p><strong>Interpretation</strong>
Our results expand the phenotypical and molecular spectrum of TRIP4‐associated disease to include mild adult forms with or without cardiomyopathy, associate ASC‐1 depletion with isolated primary muscle involvement, and establish TRIP4 as a causative gene for several congenital muscle diseases, including nemaline, core, centronuclear, and cytoplasmic‐body myopathies. They also identify ASC‐1 as a novel cell cycle regulator with a key role in cell proliferation, and underline transcriptional coregulation defects as a novel pathophysiological mechanism. </p> |
| first_indexed | 2024-03-07T00:58:21Z |
| format | Journal article |
| id | oxford-uuid:88db6cd7-7628-48c3-b7e6-acd92f31f075 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T00:58:21Z |
| publishDate | 2019 |
| publisher | Wiley |
| record_format | dspace |
| spelling | oxford-uuid:88db6cd7-7628-48c3-b7e6-acd92f31f0752022-03-26T22:20:28ZASC-1 is a cell cycle regulator associated with severe and mild forms of myopathyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:88db6cd7-7628-48c3-b7e6-acd92f31f075EnglishSymplectic ElementsWiley2019Villar-Quiles, RNCatervi, FCabet, EJuntas-Morales, RGenetti, CAGidaro, TKoparir, AYüksel, ACoppens, SDeconinck, NPierce-Hoffman, ELornage, XDurigneux, JLaporte, JRendu, JRomero, NBBeggs, AHServais, LJPCossée, MOlivé, MBöhm, JDuband-Goulet, IFerreiro, A<p><strong>Objective</strong> Recently, the ASC‐1 complex has been identified as a mechanistic link between amyotrophic lateral sclerosis and spinal muscular atrophy (SMA), and 3 mutations of the ASC‐1 gene TRIP4 have been associated with SMA or congenital myopathy. Our goal was to define ASC‐1 neuromuscular function and the phenotypical spectrum associated with TRIP4 mutations.</p> <p><strong>Methods</strong> Clinical, molecular, histological, and magnetic resonance imaging studies were made in 5 families with 7 novel TRIP4 mutations. Fluorescence activated cell sorting and Western blot were performed in patient‐derived fibroblasts and muscles and in Trip4 knocked‐down C2C12 cells.</p> <p><strong>Results</strong> All mutations caused ASC‐1 protein depletion. The clinical phenotype was purely myopathic, ranging from lethal neonatal to mild ambulatory adult patients. It included early onset axial and proximal weakness, scoliosis, rigid spine, dysmorphic facies, cutaneous involvement, respiratory failure, and in the older cases, dilated cardiomyopathy. Muscle biopsies showed multiminicores, nemaline rods, cytoplasmic bodies, caps, central nuclei, rimmed fibers, and/or mild endomysial fibrosis. ASC‐1 depletion in C2C12 and in patient‐derived fibroblasts and muscles caused accelerated proliferation, altered expression of cell cycle proteins, and/or shortening of the G0/G1 cell cycle phase leading to cell size reduction.</p> <p><strong>Interpretation</strong> Our results expand the phenotypical and molecular spectrum of TRIP4‐associated disease to include mild adult forms with or without cardiomyopathy, associate ASC‐1 depletion with isolated primary muscle involvement, and establish TRIP4 as a causative gene for several congenital muscle diseases, including nemaline, core, centronuclear, and cytoplasmic‐body myopathies. They also identify ASC‐1 as a novel cell cycle regulator with a key role in cell proliferation, and underline transcriptional coregulation defects as a novel pathophysiological mechanism. </p> |
| spellingShingle | Villar-Quiles, RN Catervi, F Cabet, E Juntas-Morales, R Genetti, CA Gidaro, T Koparir, A Yüksel, A Coppens, S Deconinck, N Pierce-Hoffman, E Lornage, X Durigneux, J Laporte, J Rendu, J Romero, NB Beggs, AH Servais, LJP Cossée, M Olivé, M Böhm, J Duband-Goulet, I Ferreiro, A ASC-1 is a cell cycle regulator associated with severe and mild forms of myopathy |
| title | ASC-1 is a cell cycle regulator associated with severe and mild forms of myopathy |
| title_full | ASC-1 is a cell cycle regulator associated with severe and mild forms of myopathy |
| title_fullStr | ASC-1 is a cell cycle regulator associated with severe and mild forms of myopathy |
| title_full_unstemmed | ASC-1 is a cell cycle regulator associated with severe and mild forms of myopathy |
| title_short | ASC-1 is a cell cycle regulator associated with severe and mild forms of myopathy |
| title_sort | asc 1 is a cell cycle regulator associated with severe and mild forms of myopathy |
| work_keys_str_mv | AT villarquilesrn asc1isacellcycleregulatorassociatedwithsevereandmildformsofmyopathy AT catervif asc1isacellcycleregulatorassociatedwithsevereandmildformsofmyopathy AT cabete asc1isacellcycleregulatorassociatedwithsevereandmildformsofmyopathy AT juntasmoralesr asc1isacellcycleregulatorassociatedwithsevereandmildformsofmyopathy AT genettica asc1isacellcycleregulatorassociatedwithsevereandmildformsofmyopathy AT gidarot asc1isacellcycleregulatorassociatedwithsevereandmildformsofmyopathy AT koparira asc1isacellcycleregulatorassociatedwithsevereandmildformsofmyopathy AT yuksela asc1isacellcycleregulatorassociatedwithsevereandmildformsofmyopathy AT coppenss asc1isacellcycleregulatorassociatedwithsevereandmildformsofmyopathy AT deconinckn asc1isacellcycleregulatorassociatedwithsevereandmildformsofmyopathy AT piercehoffmane asc1isacellcycleregulatorassociatedwithsevereandmildformsofmyopathy AT lornagex asc1isacellcycleregulatorassociatedwithsevereandmildformsofmyopathy AT durigneuxj asc1isacellcycleregulatorassociatedwithsevereandmildformsofmyopathy AT laportej asc1isacellcycleregulatorassociatedwithsevereandmildformsofmyopathy AT renduj asc1isacellcycleregulatorassociatedwithsevereandmildformsofmyopathy AT romeronb asc1isacellcycleregulatorassociatedwithsevereandmildformsofmyopathy AT beggsah asc1isacellcycleregulatorassociatedwithsevereandmildformsofmyopathy AT servaisljp asc1isacellcycleregulatorassociatedwithsevereandmildformsofmyopathy AT cosseem asc1isacellcycleregulatorassociatedwithsevereandmildformsofmyopathy AT olivem asc1isacellcycleregulatorassociatedwithsevereandmildformsofmyopathy AT bohmj asc1isacellcycleregulatorassociatedwithsevereandmildformsofmyopathy AT dubandgouleti asc1isacellcycleregulatorassociatedwithsevereandmildformsofmyopathy AT ferreiroa asc1isacellcycleregulatorassociatedwithsevereandmildformsofmyopathy |